Flight Opportunities
Large-Scope Bioprinting in Microgravity
Project Description
The Large-Scope Bioprinting in Microgravity project is a suborbital flight test of a bioprinter prototype as proof of concept for a full scale, commercial bioprinting facility hosted at a future low-Earth orbit facility (e.g. the International Space Station). Bioprinting in microgravity could allow for the large-scale production of multiple cell types more efficiently than on Earth. Researchers aim to test print basic 3D structures to examine the quality of the product and the functionality of the hardware.
More »
Anticipated Benefits
Bioprinting in microgravity might enable mass production of organoids and complex scaffolds, which can potentially provide cost-effective alternatives to animal studies and contribute to artificial organ development. Bioprinting in 0 g should produce more viable cells than in 1 g due to the absence of thickeners that can affect cell viability. This has the potential to contribute to medical advances on Earth and to benefit NASA missions, the commercial space industry, other government agencies, and the nation.
More »
Primary U.S. Work Locations and Key Partners
| Organizations Performing Work | Role | Type | Location |
|---|---|---|---|
| Center for Applied Space Technology (CAST) | Lead Organization | Industry | Orange Park, Florida |
Primary U.S. Work Locations
-
Florida
Suggest an Edit
Recommend changes and additions to this project record.